AUDIO-Wake up and think about my prostate cancer in 15 years
Patients beware: A lawyer is running the world’s biggest drugmaker, Pfizer, while an efficiency expert is leading Merck.
And that means one thing — developing treatments for your ailment of tomorrow is not at the top of their list, according to Thermo Fisher CEO Marijn Dekkers. Instead, major drugmakers weighed down with regulatory and legal issues are turning to new CEOs who don’t own a lab coat to steer them through these rocky waters.
It’s a short-sighted move, in his opinion, that puts another hurdle in front of their pursuit to discover new medicines.